Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f19b9a711398eecbe5238d5c692e6e2e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2014-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080fbbb4624950ed60a9fb45933172fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76658e4fce22992f3078f1a8af80f547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b5ae62c604e33380061a02b80dcf22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_122f28fd87038f5842273a90b9967260 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3180bf9fd6487b487bc484d7a33b6736 |
publicationDate |
2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9320754-B2 |
titleOfInvention |
Maintenance of platelet inhibition during antiplatelet therapy |
abstract |
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients in need of antiplatelet therapy or at risk of thrombosis. The method can further be used in patients who were previously treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510934-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10022391-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231987-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017049798-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744149-B2 |
priorityDate |
2008-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |